The manufacturer of popular convenience store vaping brand Blu has submitted marketing applications to the FDA for its myblu pod-based products.
The FDA has sent warning letters to several vaping manufacturers and retailers, citing them for sales of products that violate FDA marketing rules.
The French government has limited sales of pharmaceutical nicotine after the announcement of a clinical study of nicotine as a treatment for COVID-19.
Two groups of researchers are suggesting that nicotine could prevent coronavirus infections and be used to treat current COVID-19 patients.
The FDA will delay the premarket review requirement for all vaping products for four months. The new deadline for PMTA submission will be Sept. 9.
Florida vape consumers and businesses are urging governor Ron DeSantis to veto a recently passed bill banning sales of flavored vaping products.
The FDA has denied a request from a House subcommittee chairman to temporarily ban sales of vaping products during the coronavirus crisis.
Federal regulators charge the deal that gave Altria a 35 percent share in e-cigarette market leader JUUL Labs was anti-competitive and illegal.
New York will become the fourth state to ban flavored vaping products when Gov. Cuomo signs a bill passed by the state legislature.
A U.S. House subcommittee chairman has asked the FDA to temporarily ban all vaping products during the coronavirus epidemic.